Immunological changes after COVID-19 vaccination in an HIV-positive patient
•Vaccination is an essential and promising way to cope with the COVID-19 pandemic.•We report the case of an HIV-positive patient showing deterioration after vaccination.•Caution should be taken when vaccinating HIV-positive patients who are not on medication. Vaccination is an essential measure to s...
Saved in:
| Published in | International journal of infectious diseases Vol. 117; pp. 230 - 232 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Canada
Elsevier Ltd
01.04.2022
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Vaccination is an essential and promising way to cope with the COVID-19 pandemic.•We report the case of an HIV-positive patient showing deterioration after vaccination.•Caution should be taken when vaccinating HIV-positive patients who are not on medication.
Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy. |
|---|---|
| AbstractList | Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy. •Vaccination is an essential and promising way to cope with the COVID-19 pandemic.•We report the case of an HIV-positive patient showing deterioration after vaccination.•Caution should be taken when vaccinating HIV-positive patients who are not on medication. Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy. Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy.Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy. |
| Author | Song, Xiaojing Li, Xiaoxia Lu, Lianfeng Gong, Changlin Li, Taisheng |
| Author_xml | – sequence: 1 givenname: Changlin orcidid: 0000-0001-9932-0538 surname: Gong fullname: Gong, Changlin – sequence: 2 givenname: Xiaojing surname: Song fullname: Song, Xiaojing – sequence: 3 givenname: Xiaoxia surname: Li fullname: Li, Xiaoxia – sequence: 4 givenname: Lianfeng surname: Lu fullname: Lu, Lianfeng – sequence: 5 givenname: Taisheng orcidid: 0000-0002-7050-5675 surname: Li fullname: Li, Taisheng email: litsh@263.net |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34419582$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhSNURB_wB1igLNkk-JXERggJDY9GVOoGurU8N9dTh4w92JmR-u_xdFpEuygrW773fMe-x6fFkQ8ei-I1JTUltH031m50Q80IozWRNeHqWXFCZScr3lB6lPeM0Ep1lB0XpymNhBDRtvJFccyFoKqR7KT43q_XWx-msHJgphKujV9hKo2dMZaLy6v-c0VVuTMAzpvZBV86XxpfnvdX1SYkN7sdlptcQT-_LJ5bMyV8dbeeFT-_fvmxOK8uLr_1i08XFTQdmytswTRckra1UnXcLgkOgjJgnV0iDp0FwfNNQVjLLLEGlQVE26hBUZQE-VnRH7hDMKPeRLc28UYH4_TtQYgrbeLsYEJtGtMgVcgFlwKYXFLKKSFo6DAIYmVmfTywNtvlGgfIz4hmegB9WPHuWq_CTkveZWSbAW_vADH83mKa9dolwGkyHsM2ada0vKNcqCa3vvnX66_JfRq5QR4aIIaUIloNbr6derZ2k6ZE74PXo94Hr_fBayJ1Dj5L2SPpPf1J0YeDCHNaO4dRJ8hBAg4uIsx5nO5p-ftHcpic3_-jX3jzP_Ef9FDa9w |
| CitedBy_id | crossref_primary_10_2147_PPA_S342801 crossref_primary_10_1002_jmv_29334 crossref_primary_10_1080_22221751_2022_2059401 crossref_primary_10_1002_jmv_29820 crossref_primary_10_2989_16085906_2022_2118615 crossref_primary_10_2478_prolas_2024_0015 crossref_primary_10_3390_v15122427 crossref_primary_10_1016_j_socscimed_2024_116920 crossref_primary_10_4103_aam_aam_13_23 |
| Cites_doi | 10.1016/S0264-410X(99)00321-7 10.1182/blood.V86.3.1082.1082 10.1056/NEJMoa2034577 10.1093/infdis/jiu606 10.1001/jamanetworkopen.2020.37069 10.1056/NEJMoa2035389 10.1056/NEJM199605093341903 10.1016/S0140-6736(21)01429-X 10.1016/S0140-6736(20)32466-1 10.1371/journal.pone.0199229 10.1089/apc.1997.11.269 10.1093/ofid/ofab343 10.3389/fimmu.2020.596631 10.1001/jama.2021.8565 |
| ContentType | Journal Article |
| Copyright | 2021 Copyright © 2021. Published by Elsevier Ltd. 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021 |
| Copyright_xml | – notice: 2021 – notice: Copyright © 2021. Published by Elsevier Ltd. – notice: 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1016/j.ijid.2021.08.039 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals - May need to register for free articles |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1878-3511 |
| EndPage | 232 |
| ExternalDocumentID | oai_doaj_org_article_a5a5e19e34384c28b113100ea1dd40f8 PMC8373846 34419582 10_1016_j_ijid_2021_08_039 S1201971221006676 |
| Genre | Case Reports |
| GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW NCXOZ RIG AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c572t-e6ca538066f8973fb0ed412c27fbeed7fc43004c4ff2f0fae9fceef59d91e80e3 |
| IEDL.DBID | .~1 |
| ISSN | 1201-9712 1878-3511 |
| IngestDate | Wed Aug 27 01:06:32 EDT 2025 Thu Aug 21 14:02:30 EDT 2025 Fri Jul 11 01:35:23 EDT 2025 Tue Apr 29 09:42:34 EDT 2025 Tue Jul 01 04:30:08 EDT 2025 Thu Apr 24 22:51:12 EDT 2025 Fri Feb 23 02:38:45 EST 2024 Tue Aug 26 16:32:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Vaccine Human immunodeficiency virus Coronavirus disease 2019 CD4+ T cells |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2021. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c572t-e6ca538066f8973fb0ed412c27fbeed7fc43004c4ff2f0fae9fceef59d91e80e3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0001-9932-0538 0000-0002-7050-5675 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1201971221006676 |
| PMID | 34419582 |
| PQID | 2563713495 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a5a5e19e34384c28b113100ea1dd40f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373846 proquest_miscellaneous_2563713495 pubmed_primary_34419582 crossref_citationtrail_10_1016_j_ijid_2021_08_039 crossref_primary_10_1016_j_ijid_2021_08_039 elsevier_sciencedirect_doi_10_1016_j_ijid_2021_08_039 elsevier_clinicalkey_doi_10_1016_j_ijid_2021_08_039 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-04-01 |
| PublicationDateYYYYMMDD | 2022-04-01 |
| PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Canada |
| PublicationPlace_xml | – name: Canada |
| PublicationTitle | International journal of infectious diseases |
| PublicationTitleAlternate | Int J Infect Dis |
| PublicationYear | 2022 |
| Publisher | Elsevier Ltd Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases – name: Elsevier |
| References | Stanley, Ostrowski, Justement, Gantt, Hedayati, Mannix (bib0009) 1996; 334 O'Brien, Grovit-Ferbas, Namazi, Ovcak-Derzic, Wang, Park (bib0007) 1995; 86 Peng, Ouyang, Isnard, Lin, Fombuena, Zhu (bib0006) 2020; 11 Polack, Thomas, Kitchin, Absalon, Gurtman, Lockhart (bib0016) 2020; 383 Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States [Internet]. US: Centers for Disease Control and Prevention; [updated 2021 Apr 27; cited 1 May 2021 ]. Available from Eisinger, Lerner, Fauci (bib0003) 2021 Baden, El Sahly, Essink, Kotloff, Frey, Novak (bib0015) 2021; 384 . (bib0011) 2021; 60 Al Kaabi, Zhang, Xia, Yang, Al Qahtani, Abdulrazzaq (bib0012) 2021; 326 Tesoriero, Swain, Pierce, Zamboni, Wu, Holtgrave (bib0004) 2021; 4 Katzenstein (bib0008) 1997; 11 Rousseau, Moreau, Delmont (bib0010) 1999; 18 Haynes (bib0002) 2021 Jawed, Khalid, Rubin, Shafiq, Cemalovic (bib0005) 2021; 8 Ramasamy, Minassian, Ewer, Flaxman, Folegatti, Owens (bib0017) 2021; 396 Tanriover, Doğanay, Akova, Güner, Azap, Akhan (bib0013) 2021 Yang, Li, Dai, Wang, He, Li (bib0018) 2021; S1473-3099 Su, Ng, Lewis, Cano (bib0001) 2018; 13 Berkowitz, Moyle, Stellbrink, Schürmann, Kegg, Stoll (bib0019) 2015; 211 Peng (10.1016/j.ijid.2021.08.039_bib0006) 2020; 11 Tanriover (10.1016/j.ijid.2021.08.039_bib0013) 2021 Jawed (10.1016/j.ijid.2021.08.039_bib0005) 2021; 8 (10.1016/j.ijid.2021.08.039_bib0011) 2021; 60 Berkowitz (10.1016/j.ijid.2021.08.039_bib0019) 2015; 211 Katzenstein (10.1016/j.ijid.2021.08.039_bib0008) 1997; 11 Stanley (10.1016/j.ijid.2021.08.039_bib0009) 1996; 334 Tesoriero (10.1016/j.ijid.2021.08.039_bib0004) 2021; 4 Baden (10.1016/j.ijid.2021.08.039_bib0015) 2021; 384 Rousseau (10.1016/j.ijid.2021.08.039_bib0010) 1999; 18 Haynes (10.1016/j.ijid.2021.08.039_bib0002) 2021 Polack (10.1016/j.ijid.2021.08.039_bib0016) 2020; 383 O'Brien (10.1016/j.ijid.2021.08.039_bib0007) 1995; 86 Ramasamy (10.1016/j.ijid.2021.08.039_bib0017) 2021; 396 10.1016/j.ijid.2021.08.039_bib0014 Yang (10.1016/j.ijid.2021.08.039_bib0018) 2021; S1473-3099 Su (10.1016/j.ijid.2021.08.039_bib0001) 2018; 13 Al Kaabi (10.1016/j.ijid.2021.08.039_bib0012) 2021; 326 Eisinger (10.1016/j.ijid.2021.08.039_bib0003) 2021 |
| References_xml | – volume: 334 start-page: 1222 year: 1996 end-page: 1230 ident: bib0009 article-title: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1 publication-title: N Engl J Med – volume: 396 start-page: 1979 year: 2021 end-page: 1993 ident: bib0017 article-title: Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial publication-title: Lancet – volume: 13 year: 2018 ident: bib0001 article-title: Adverse events after vaccination among HIV-positive persons, 1990-2016 publication-title: PLoS One – volume: 384 start-page: 403 year: 2021 end-page: 416 ident: bib0015 article-title: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine publication-title: N Engl J Med – volume: 11 year: 2020 ident: bib0006 article-title: Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System publication-title: Front Immunol – start-page: 1 year: 2021 end-page: 2 ident: bib0002 article-title: SARS-CoV-2 and HIV-1 - a tale of two vaccines publication-title: Nat Rev Immunol – start-page: jiab114 year: 2021 ident: bib0003 article-title: HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics publication-title: J Infect Dis – volume: 18 start-page: 825 year: 1999 end-page: 831 ident: bib0010 article-title: Vaccination and HIV: a review of the literature publication-title: Vaccine – reference: . – volume: 383 start-page: 2603 year: 2020 end-page: 2615 ident: bib0016 article-title: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine publication-title: N Engl J Med – volume: 60 start-page: 615 year: 2021 end-page: 618 ident: bib0011 article-title: Chinese Society of Infectious Diseases. Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection publication-title: Chin J Intern Med – volume: 86 start-page: 1082 year: 1995 end-page: 1089 ident: bib0007 article-title: Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination publication-title: Blood – year: 2021 ident: bib0013 article-title: Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey publication-title: Lancet – volume: 8 start-page: ofab343 year: 2021 ident: bib0005 article-title: Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP publication-title: Open Forum Infect Dis – volume: 211 start-page: 1279 year: 2015 end-page: 1287 ident: bib0019 article-title: Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study publication-title: J Infect Dis – volume: 326 start-page: 35 year: 2021 end-page: 45 ident: bib0012 article-title: Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial publication-title: JAMA – volume: 4 year: 2021 ident: bib0004 article-title: COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State publication-title: JAMA Netw Open – volume: 11 start-page: 269 year: 1997 end-page: 275 ident: bib0008 article-title: Pneumococcal vaccination of HIV-infected individuals: safety and efficacy publication-title: AIDS Patient Care STDS – volume: S1473-3099 start-page: 00124 year: 2021 end-page: 00127 ident: bib0018 article-title: Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials publication-title: Lancet Infect Dis – reference: Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States [Internet]. US: Centers for Disease Control and Prevention; [updated 2021 Apr 27; cited 1 May 2021 ]. Available from: – volume: 18 start-page: 825 issue: 9-10 year: 1999 ident: 10.1016/j.ijid.2021.08.039_bib0010 article-title: Vaccination and HIV: a review of the literature publication-title: Vaccine doi: 10.1016/S0264-410X(99)00321-7 – volume: 86 start-page: 1082 issue: 3 year: 1995 ident: 10.1016/j.ijid.2021.08.039_bib0007 article-title: Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination publication-title: Blood doi: 10.1182/blood.V86.3.1082.1082 – volume: 383 start-page: 2603 issue: 27 year: 2020 ident: 10.1016/j.ijid.2021.08.039_bib0016 article-title: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2034577 – volume: 211 start-page: 1279 issue: 8 year: 2015 ident: 10.1016/j.ijid.2021.08.039_bib0019 article-title: Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study publication-title: J Infect Dis doi: 10.1093/infdis/jiu606 – volume: 4 issue: 2 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0004 article-title: COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.37069 – volume: 384 start-page: 403 issue: 5 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0015 article-title: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2035389 – volume: 60 start-page: 615 issue: 7 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0011 article-title: Chinese Society of Infectious Diseases. Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection publication-title: Chin J Intern Med – volume: 334 start-page: 1222 issue: 19 year: 1996 ident: 10.1016/j.ijid.2021.08.039_bib0009 article-title: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1 publication-title: N Engl J Med doi: 10.1056/NEJM199605093341903 – year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0013 article-title: Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey publication-title: Lancet doi: 10.1016/S0140-6736(21)01429-X – volume: 396 start-page: 1979 issue: 10267 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0017 article-title: Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial publication-title: Lancet doi: 10.1016/S0140-6736(20)32466-1 – ident: 10.1016/j.ijid.2021.08.039_bib0014 – volume: S1473-3099 start-page: 00124 issue: 21 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0018 article-title: Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials publication-title: Lancet Infect Dis – volume: 13 issue: 6 year: 2018 ident: 10.1016/j.ijid.2021.08.039_bib0001 article-title: Adverse events after vaccination among HIV-positive persons, 1990-2016 publication-title: PLoS One doi: 10.1371/journal.pone.0199229 – volume: 11 start-page: 269 issue: 4 year: 1997 ident: 10.1016/j.ijid.2021.08.039_bib0008 article-title: Pneumococcal vaccination of HIV-infected individuals: safety and efficacy publication-title: AIDS Patient Care STDS doi: 10.1089/apc.1997.11.269 – start-page: jiab114 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0003 article-title: HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics publication-title: J Infect Dis – start-page: 1 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0002 article-title: SARS-CoV-2 and HIV-1 - a tale of two vaccines publication-title: Nat Rev Immunol – volume: 8 start-page: ofab343 issue: 7 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0005 article-title: Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofab343 – volume: 11 year: 2020 ident: 10.1016/j.ijid.2021.08.039_bib0006 article-title: Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System publication-title: Front Immunol doi: 10.3389/fimmu.2020.596631 – volume: 326 start-page: 35 issue: 1 year: 2021 ident: 10.1016/j.ijid.2021.08.039_bib0012 article-title: Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial publication-title: JAMA doi: 10.1001/jama.2021.8565 |
| SSID | ssj0004668 |
| Score | 2.3815198 |
| Snippet | •Vaccination is an essential and promising way to cope with the COVID-19 pandemic.•We report the case of an HIV-positive patient showing deterioration after... Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a... Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 230 |
| SubjectTerms | CD4+ T cells CD4-Positive T-Lymphocytes Coronavirus disease 2019 COVID-19 - prevention & control COVID-19 Vaccines HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Humans Vaccination Vaccine |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals - May need to register for free articles dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDwgJISiv8JKRuCGL2I5j-wiFahdUuNCqN8tPkQqliG77-_HYSbQLUnvhmsSJ7Bl7vtjzfYPQm15Yx2lwhDuqSMdVT3TimuTYxDPkD1wVhvfR13513H0-Fadbpb4gJ6zKA9eBe2eFFZHqyPN7Os-UoxT2pKOlIXRtKjTfHPPmn6mFEVlJcDm8ES0pm-gyNbNrOBtAI5RV8U4oE74Vkopy_05k-hd5_p1AuRWRDu-jexOUxO9rFx6gW3HcR7ePpsPyfXS3bsnhyjR6iL6sgQsyL3a4Un4vcKkSjg--naw_EqrxlfW5ebEXHkZsR7xan5Ca23UV8aTD-ggdH376frAiUy0F4oVkGxJ7b_PalgFGUlry5NoYOso8k8nlMCmT70B7y3cpsdQmG3XK4TMJHTSNqo38Mdobz8f4FOHgImwctRaEYpTkoDjIey9lGzSLLjSIzsNp_CQ0DvUufpo5o-zMgAkMmMBAEUyuG_R2afOrymxc-_QHsNLyJEhklwvZcczkOOYmx2kQn21sZhZqXjfzi4ZrPy2WVhNGqdjjxnavZzcyeQLDqYwd4_nlhcmYkxeRSNGgJ9Wtlo7xDFa1UKxBcsfhdnq-e2ccfhSRcAWSVV3_7H8M1XN0hwHroyQsvUB7m9-X8WXGYhv3qky7PxgiLc8 priority: 102 providerName: Directory of Open Access Journals |
| Title | Immunological changes after COVID-19 vaccination in an HIV-positive patient |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971221006676 https://dx.doi.org/10.1016/j.ijid.2021.08.039 https://www.ncbi.nlm.nih.gov/pubmed/34419582 https://www.proquest.com/docview/2563713495 https://pubmed.ncbi.nlm.nih.gov/PMC8373846 https://doaj.org/article/a5a5e19e34384c28b113100ea1dd40f8 |
| Volume | 117 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhASQlBe4VEZiRsyG9tJbB_plmpDVThAq71ZTmKXVChbtdse-e14bGe1AalIXHJI7MTxTGYm9nzfIPSuKk3DadcQ3lBJCi4rohxXxPsm7kP-jsuA8D75Ui1Oi8_LcrmD5iMWBtIqk-2PNj1Y63RmlmZzdtn3s2_U-y4lKPM_LSFTExDshQAt__CLbmEjIxzONybQOgFnYo5Xf9EDWyiLNJ5QMHzLOQUO_4mP-jsG_TOVcss3HT1CD1NQiT_GcT9GO3bYQ_dO0rb5HnoQF-dwxBw9Qcc1oEJGs4cj-Pcah3rheP71rD4kVOFb0_ruQXK4H7AZ8KI-IzHL69bixMj6FJ0effo-X5BUVYG0pWBrYqvWeCvnp8xJJbhrctsVlLVMuMY7TOHaAli42sI55nJnrHLekbpSdYpamVv-DO0Oq8G-QLhrLCwh5QYoY6TgwD3Iq1aIvFPMNl2G6Diduk2U41D54qcec8suNIhAgwg0lMPkKkPvN30uI-HGna0PQEqblkCWHU6srs510hZtSlNaqiz3qli0TDaUwraGNbTritzJDPFRxnrEo3oL6m_U3_noctNrorH_7Pd2VCPtP2XYnzGDXd1cax998kAXWWboeVSrzYtxH7aqUrIMiYnCTd58emXofwS6cAnkVUX18j_H-wrdZwD5CNlKr9Hu-urGvvGB2LrZD1-aPx7Wx_thMcMf6-XBb3LyMYY |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgESQlBe4WkkOKGwsZ2XDxygpdqw3XKgrXpz87AhFcpW3W0RF_4Uf5DxI6sNSEVC6jWb8Tqe8cwknu8bgJdpUlacNlXIK5qHMc_TUGguQoxNHFP-hucW4T3dTcf78cfD5HANfvVYGFNW6X2_8-nWW_srI7-ao5O2HX2mGLtERhm-tNhKTV9ZOVE_vuN72_xtsYVKfsXY9oe9zXHoWwuEdZKxRajSusStjnI6FxnXVaSamLKaZbrCqJHpOjZUVHWsNdORLpXQGE10IhpBVR4pjuNegasxjmHaJrz5SVfAmA5_h7MLzfQ8UscVlbXHraEnZY431HQoX4mGtmnAICj-nfT-Wbu5Egy3b8Mtn8WSd26h7sCa6jbg2tSf02_ATfc1kDiQ012YFAaG0vtZ4tDGc2IblJPNTwfFVkgFOS9rFLemQtqOlB0ZFwehKys7V8RTwN6D_UtZ6_uw3s069RBIUynzzSoqDUdNnnFDdsjTOsuiRjBVNQHQfjll7TnOTauNb7IvZjuWRgXSqECa_ptcBPB6KXPiGD4uvPu90dLyTsPObS_MTr9Ib56yTMpEUaE42n5cs7yi1JyjqJI2TRzpPADe61j2AFh02ThQe-FfJ0upwRb5p9yL3owk-g5zIFR2anY2l5jucstPmQTwwJnV8sE45skiyVkA2cDgBk8-_KVrv1p-8tywZcXpo_-c73O4Pt6b7sidYnfyGG4wgzexpVJPYH1xeqaeYha4qJ7ZXUfg6LK3-W_AIW5S |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunological+changes+after+COVID-19+vaccination+in+an+HIV-positive+patient&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Gong%2C+Changlin&rft.au=Song%2C+Xiaojing&rft.au=Li%2C+Xiaoxia&rft.au=Lu%2C+Lianfeng&rft.date=2022-04-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.volume=117&rft.spage=230&rft.epage=232&rft_id=info:doi/10.1016%2Fj.ijid.2021.08.039&rft.externalDocID=S1201971221006676 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |